Man survives with brother's kidney despite mismatchTimes of IndiaWe administered the patient with a drug called Rituximab to reduce antibodies in his blood. Pyaare's blood type is O while his brother's is type B," said Dr Sanjiv Jasuja…
The Oncology ReportFake and Gray Market Drugs Vex US OncologistsThe Oncology ReportThe agency named Faslodex (fulvestrant), Neupogen (filgrastim), Rituxan (rituximab) and Herceptin (trastuzumab) – but not Avastin – in the warning. Subsequently, the…
Chinese Monoclonal Antibody Industry 2012 Research ReportSBWire (press release)Roche is the biggest winner in monoclonal antibody market, and the products with the largest market share; Rituximab and Trastuzumab, are from Roche Group. Merck and Novarti…
HemOncTodayLow-dose rituximab plus steroids demonstrated safety, efficacy in autoimmune …HemOncTodayThe combination of low-dose rituximab and steroids was linked to overall response rates of more than 80% in a cohort of patients with autoimmune hemol…
Chronic Lymphocytic Leukemia – Aggressive Drug Combo Restores Quality Of LifeMedical News TodayFC in combination with rituximab, a monoclonal antibody drug, has proven to be the most effective therapy for extending life and has become the standard trea…
OncLiveNoteworthy Research Spans Range of MalignanciesOncLiveRituximab antibodies (turquoise) bind to the CD20 cell-surface markers on B-cells. A second paper reported the results of a most interesting phase III randomized trial that the Eastern Cooper…
IMARC Group Releases the Most Comprehensive Study on the US Follow-on …PharmiWeb.com (press release)… Interferon Beta-1A (Rebif), Interferon Beta-1B (Betaferon), Bevacizumab (Avastin), Trastuzumab (Herceptin), Rituximab (Mabthera/Rituxan), Cetuxima…
InPharmIndian CMO will make Roche blockbustersInPharmMeanwhile, a separate report in the Economic Times has suggested that the deal could also be extended to cover Roche's non-Hodgkin's lymphoma therapy MabThera/Rituxan (rituximab). The deal is…
Study offers reassurance to leukaemia patientsHealthCanal.comThe combination of FC with the monoclonal antibody drug rituximab has since been shown to be the most effective treatment option for extending survival and this is now the standard treatment …
Soft Tissue Tumor Recurrence After Intramedullary Stabilization of Impending …Ortho SuperSiteShe was treated with rituximab and CHOP, a type of chemotherapy that consists of 4 drugs: cyclophosphamide, doxorubicin, vincristine, and prednisolone, and o…